This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the … benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences … contributions to health insurance. As one would expect, non-affected non-diabetics and insulin-naive diabetics exhibit higher …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … ; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …

chain of an emerging new product and how they contribute to innovation. Further, user innovation success in the market is … studies in the healthcare sector have shown that healthcare professionals are an important source of innovation. Yet, to date …

their product to market. Our findings show that these innovation opportunities were mostly recognized during time … cases, the innovation had significant impacts on the quality of lives of the patients and, in case of caregivers, on both … ailment. This finding on innovation's social component complements current research on lead-users, as the solution of one …